Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins

Toxicon

Volumn 42, Issue 7, 2003, Pages 785-791

  Meddeb Mouelhi, Fatma ^a   Bouhaouala Zahar, Balkiss ^a,b   Benlasfar, Zakaria ^a   Hammadi, Mohamed ^c   Mejri, Thouraya ^a   Moslah, Mekki ^c   Karoui, Habib ^a   Khorchani, Touhami ^c   Ayeb, Mohamed El ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c INSTITUT DES RÉGIONS ARIDES   (Tunisia)

Author keywords

Antigenic reactivity; Heavy chain camel immunoglobulin; Lethal dose; Neutralizing capacity; Scorpion toxins; Serotherapy

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUROTOXIN; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; SCORPION VENOM;

ANDROCTONUS AUSTRALIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CAMEL; CONTROLLED STUDY; IMMUNIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; SCORPION;

ANDROCTONUS; ANDROCTONUS AUSTRALIS HECTOR; CAMELIDAE; CAMELUS DROMEDARIUS; EQUIDAE; SCORPIONES;

EID: 1642493838     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2003.10.021     Document Type: Article

References (23)

1. Bouhaouala-Zahar B., Ducancel F., Zenouaki I., Ben Khalifa R., Borchani L., Pelhate M., Boulain J.C., El Ayeb M., Menez A., Karoui H. A recombinant insect-specific α-toxin of Buthus occitanus tunetanus scorpion confers protection against homologous mammal toxins. Eur. J. Biochem. 238:1996;653-660.
2. Chavez-Olortegui C., Ait Amara D., Rochat H., Diniz C., Granier C. In vivo protection against scorpion toxins by liposomal immunization. Vaccine. 9:1991;907-910.
3. Ghahroudi M.A., Desmyter A., Wyns L., Hamers R., Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 414:1997;521-526.
4. Goyffon M., Vachon M., Broglio N. Epidemiology and clinical characteristics of scorpion envenomation in Tunisia. Toxicon. 20:1982;337-344.
5. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Bajyana Songa E., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 363:1993;446-448.
6. Ismail M., Ellison A.C., Tilmisamy A.K. Pharmacokinetics of 125I-labelled antivenom to the venom of the scorpion Androctonus amoreuxi. Toxicon. 21:1983;177-198.
7. Ismail M., Adb-Esalam A. Are the toxicolgical effects of scorpion envenomation related to issue venom concentration? Toxicon. 26:1988;233-256.
8. Ismail M. The scorpion envenoming syndrome. Toxicon. 33:1995;825-858.
9. Ismail M. Treatment of the scorpion envenoming syndrome: 12 years experience with serotherapy. Int. J. Antimicrob. Agents. 21:2003;253-261.
10. Krifi M.N., El Ayeb M., Ben Lasfar Z., Miled K., Dellagi K. Improvement and standardization of antivenom sera. Arch. Inst. Pasteur. Tunis. 69:1992;253-261.
11. Krifi M.N., El Ayeb M., El Afrit L., Dellagi K. Toxicocinétique et sérothérapie expérimentale de l'envenimation scorpionique. Arch. Inst. Pasteur. Tunis. 71:1994;479-482.
12. Krifi M.N., El Ayeb M., Dellagi K. New procedures and parameters for better evaluation of Androctonus australis Garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion envenomations and specific serotherapy treatment. Toxicon. 34:1996;257-266.
13. Krifi M.N., Amri F., Kharrat H., El Ayeb M. Evaluation of antivenom therapy in children severely envenomed by Androctonus australis Garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpion. Toxicon. 37:1999;1627-1634.
14. Krifi M.N., Miled K., Abderrazek M., El Ayeb M. Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards an optimization of antivenom immunotherapy in a rabbit model. Toxicon. 39:2001;1317-1326.
15. Lauwereys M., Ghahroudi M.A., Desmyter A., Kinne J., Hölzer W., De Genst E., Wyns L., Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17:1998;3120-3512.
16. Martin-Eauclaire M.F., Couraud F. Scorpion neuro-toxin. effects and mechanisms. Chang L.W., Dyer R.S. Handbook of Neurotoxicity. 1995;683-716 Marcel Dekker, New York.
17. Miranda F., Kopeyan C., Rochat C., Rochat H., Lissitzky S. Purification of animal neurotoxins. Isolation and characterization of eleven neurotoxins from the venom of the scorpion Androctonus australis hector, Buthus occitanus tunetanus and Leiurus quinquestriatus quinquestriatus. Eur. J. Biochem. 16:1970;279-291.
18. Muyldermans S., Atarhouch T., Saldanha J., Barbosa J.A.R.G., Hamers R. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Engng. 7:1994;1129-1135.
19. Muyldermans S., Lauwererys M. Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J. Mol. Recog. 12:1999;131-140.
20. Reed L., Muench H. A simple method of estimating fifty percent in eucarotic end point. Am. J. Hyg. 27:1938;493-497.
21. Sambrook J., Fritsh E.F., Maniatis T. In: Molecular cloning: a laboratory manual. 2nd ed :1989;Cold spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Rochat H., Bernard P., Couraud F. Scorpion toxins: chemistry and mode of action. Adv. Cytopharmacol. 3:1979;325-330.
23. Van der Linden R., de Geus B., Stok W., Bos W., van Wassenaar D., Verrips T., Frenken L. Induction of immune reponses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J. Immunol. Meth. 240:2000;185-195.